Drug intelligence / Profile preview

acetaminophen + N-acetylcysteine

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Acetaminophen + N-acetylcysteine is a combination of two small molecule drugs. Acetaminophen (also known as paracetamol) is an analgesic and antipyretic widely used for pain relief and fever reduction. N-acetylcysteine (NAC) is an antioxidant and glutathione precursor that serves as the standard antidote for acetaminophen overdose, protecting against drug-induced hepatotoxicity by replenishing hepatic glutathione stores and directly binding toxic metabolites of acetaminophen. Co-formulation or co-administration of these agents has been shown in preclinical models to prevent liver toxicity associated with high doses of acetaminophen, suggesting a potential public health benefit if used together in over-the-counter products to reduce the risk of accidental or intentional overdose[2][3]. The combination leverages the therapeutic effects of acetaminophen while mitigating its primary safety risk—liver damage—through NAC’s protective mechanism.

Other names
APAP and NAC combinationacetaminophen and N-acetylcysteine combinationAPAP + NAC
02

Targets

GSH (Glutathione synthesis / redox)COX

Beyond the preview

Go deeper on acetaminophen + N-acetylcysteine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetaminophen + N-acetylcysteine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call